You are here: vision-research.eu » News » Newsdetails:

Cortisol-free rheumatoid arthritis medication also works for rare eye disease

A well-known rheumatoid arthritis medication containing the active agent adalimumab, a therapeutic human monoclonal antibody, is also effective for treating non-infectious uveitis, a rare eye disease.

This has now been discovered by an international research group, in which MedUni Vienna was also involved with significant participation by Talin Barisani-Asenbauer of the Center for Pathophysiology, Infectiology & Immunology and the Laura Bassi Center at MedUni Vienna. The results of the VISUAL-I study have now been published in the leading journal New England Journal of Medicine.